Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses.

Abstract:

OBJECTIVE:To study the impact of negative expectation related to receiving a placebo (the "lessebo effect") on efficacy outcome measures of symptomatic treatments in Parkinson disease (PD). METHODS:We conducted meta-analyses of double-blind randomized controlled trials (RCTs) of dopamine agonists in PD and compared the pooled mean score change of the motor section of the Unified Parkinson's Disease Rating Scale (mUPDRS) across active treatment arms according to the presence of a placebo arm or the probability of placebo assignment (0%, <50%, and 50%) of the original RCT. A mixed-effects model was used. Heterogeneity was assessed by subgroup analyses and meta-regression modeling. RESULTS:A total of 28 study arms were extracted from active-controlled trials (3,277 patients) and 42 from placebo-controlled trials (4,554 patients). The overall difference between groups in the pooled mean score change in the mUPDRS was 1.6 units (95% confidence interval [CI] 0.2, 3.0; p = 0.023), in favor of the active-controlled group. In subgroup analyses, this difference was of higher magnitude in the early PD group without motor fluctuations (3.3 mUPDRS units, 95% CI 1.1, 5.4; p = 0.003) and for study duration ≤ 12 weeks (4.1 mUPDRS units, 95% CI 1.0, 7.2; p = 0.009). There was no between-group difference using probability of placebo assignment as criterion. CONCLUSIONS:This study shows that the use of a placebo can be associated with a clinically significant reduction in the magnitude of change of the mUPDRS after an active treatment in RCTs for PD. These new findings have potential implications in the development of new treatments and appraisal of current treatment options for PD and possibly for other neurologic disorders.

journal_name

Neurology

journal_title

Neurology

authors

Mestre TA,Shah P,Marras C,Tomlinson G,Lang AE

doi

10.1212/WNL.0000000000000340

subject

Has Abstract

pub_date

2014-04-22 00:00:00

pages

1402-9

issue

16

eissn

0028-3878

issn

1526-632X

pii

WNL.0000000000000340

journal_volume

82

pub_type

杂志文章,meta分析
  • Mapping of the gene for X-linked dominant Charcot-Marie-Tooth neuropathy.

    abstract::We performed a clinical study and linkage analysis on 278 subjects (66 affected) belonging to eight families with X-linked dominant Charcot-Marie-Tooth (CMT) neuropathy. This form affects 11.8% of CMT patients in Iowa. Motor nerve conduction velocities (MNCVs) were significantly slowed consistent with type 1 CMT. Fift...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.42.4.903

    authors: Ionasescu VV,Trofatter J,Haines JL,Ionasescu R,Searby C

    更新日期:1992-04-01 00:00:00

  • Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

    abstract:OBJECTIVE:To study the association of PD with preceding smoking, alcohol, and coffee consumption using a case-control design. METHODS:The authors used the medical records linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, MN, during the years 1976 to 1995....

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.55.9.1350

    authors: Benedetti MD,Bower JH,Maraganore DM,McDonnell SK,Peterson BJ,Ahlskog JE,Schaid DJ,Rocca WA

    更新日期:2000-11-14 00:00:00

  • Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease.

    abstract::The authors used PET to show that the abnormal pattern of cerebral blood flow (CBF) activation described in PD is normalized by electrical stimulation of subthalamic nucleus. Improvement in bradykinesia correlated with increase in CBF due to stimulation in the supplementary motor area and anterior cingulate cortex. Co...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000052691.48076.92

    authors: Strafella AP,Dagher A,Sadikot AF

    更新日期:2003-03-25 00:00:00

  • Deprenyl in Parkinson disease.

    abstract::(-)Deprenyl, a specific monoamine oxidase subtype B inhibitor (MAOI-B), has been reported to be a safe and valuable adjunct to conventional treatment of parkinsonism. A double-blind, clinical comparison of (-)deprenyl with placebo was undertaken in 11 parkinsonian patients; the efficacy of 10 mg daily was studied over...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章

    doi:10.1212/wnl.31.1.19

    authors: Eisler T,Teräväinen H,Nelson R,Krebs H,Weise V,Lake CR,Ebert MH,Whetzel N,Murphy DL,Kopin IJ,Calne DB

    更新日期:1981-01-01 00:00:00

  • Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis.

    abstract::We developed a method for the detection of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) carriers. The method is based on the quantitative analysis of the products of standard multiplex polymerase chain reaction (PCR) from 18 different exons of the dystrophin gene, and is designated "QM-PCR." W...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.42.9.1783

    authors: Ioannou P,Christopoulos G,Panayides K,Kleanthous M,Middleton L

    更新日期:1992-09-01 00:00:00

  • Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins.

    abstract::Duchenne muscular dystrophy manifested in one of girl twins. The twins were monozygous on the basis of red cell and HL antigens and skin graft compatibility. Karyotyping, including banding techniques, showed a normal number of chromosomes and a normal configuration of the X-chromosome in both twins. The twins were ide...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.27.6.537

    authors: Gomez MR,Engel AG,Dewald G,Peterson HA

    更新日期:1977-06-01 00:00:00

  • Development and initial validation of a screening tool for Parkinson disease surgical candidates.

    abstract::As there is currently no standardized assessment tool for evaluating Parkinson disease (PD) patients for deep brain stimulation (DBS), the authors developed the Florida Surgical Questionnaire for Parkinson Disease (FLASQ-PD). Part I of the study was a retrospective analysis of 174 patients presenting for a surgical sc...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1212/01.wnl.0000133122.14824.25

    authors: Okun MS,Fernandez HH,Pedraza O,Misra M,Lyons KE,Pahwa R,Tarsy D,Scollins L,Corapi K,Friehs GM,Grace J,Romrell J,Foote KD

    更新日期:2004-07-13 00:00:00

  • Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group.

    abstract::Lyme borreliosis (LB) causes a range of neurologic manifestations, the most common of which is facial nerve paralysis. To evaluate nervous system LB, we organized a neurologic collaborative study group in Suffolk County, NY, a region of high LB incidence. Between July and September 1989, LB serologies were performed o...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.42.7.1268

    authors: Halperin JJ,Golightly M

    更新日期:1992-07-01 00:00:00

  • Accuracy of Calculated Free Valproate Levels in Adult Patients With Status Epilepticus.

    abstract:OBJECTIVE:To test the accuracy of an equation in adult patients with status epilepticus that calculates the free concentration of serum valproic acid (fVPA) from the total concentration of serum valproic acid (tVPA) and serum albumin. METHODS:All adult patients with status epilepticus who were treated at a Swiss acade...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000011000

    authors: Fisch U,Baumann SM,Semmlack S,Marsch S,Rüegg S,Sutter R

    更新日期:2021-01-05 00:00:00

  • Familial cerebellar ataxia with muscle coenzyme Q10 deficiency.

    abstract:OBJECTIVE:To describe a clinical syndrome of cerebellar ataxia associated with muscle coenzyme Q10 (CoQ10) deficiency. BACKGROUND:Muscle CoQ10 deficiency has been reported only in a few patients with a mitochondrial encephalomyopathy characterized by 1) recurrent myoglobinuria; 2) brain involvement (seizures, ataxia, ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.56.7.849

    authors: Musumeci O,Naini A,Slonim AE,Skavin N,Hadjigeorgiou GL,Krawiecki N,Weissman BM,Tsao CY,Mendell JR,Shanske S,De Vivo DC,Hirano M,DiMauro S

    更新日期:2001-04-10 00:00:00

  • The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1.

    abstract::Most gliomas in neurofibromatosis type 1 (NF1) are pilocytic astrocytomas (PAs) of the optic pathway occurring in young children. However, some individuals develop gliomas that lack the typical NF1-associated clinical features or radiographic appearance. We identified 17 atypical presentations from a review of 100 pat...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000240076.31298.47

    authors: Leonard JR,Perry A,Rubin JB,King AA,Chicoine MR,Gutmann DH

    更新日期:2006-10-24 00:00:00

  • A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

    abstract:OBJECTIVE:To determine the efficacy of acetyl-l-carnitine (ALCAR) on the rate of decline in early-onset AD patients. METHODS:A 1-year, multicenter, double-blind, placebo-controlled, randomized trial was conducted. Subjects were 45 to 65 years old, with a diagnosis of probable AD according to National Institute of Neur...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1212/wnl.55.6.805

    authors: Thal LJ,Calvani M,Amato A,Carta A

    更新日期:2000-09-26 00:00:00

  • Multiple cerebral hemorrhages in HTLV-I-associated myelopathy.

    abstract::We describe a 66-year-old woman with long-standing HTLV-I-associated myelopathy who developed multiple parenchymal hemorrhages and whose angiogram suggested cerebral vasculitis. After cyclophosphamide and glucocorticoid therapy, both her acute deficits and chronic paraparesis improved. HTLV-I may be an etiologic agent...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.43.2.412

    authors: Smith D,Lucas S,Jacewicz M

    更新日期:1993-02-01 00:00:00

  • Pilot trial of etanercept in the treatment of inclusion-body myositis.

    abstract::Inclusion-body myositis (IBM) is an inflammatory muscle disease that has proven resistant to treatment. Tumor necrosis factor molecules have been detected in muscle biopsies from patients with IBM. Etanercept is a TNFalpha receptor fusion protein that binds and inactivates tumor necrosis factor. Nine patients were tre...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章

    doi:10.1212/01.wnl.0000192258.32408.54

    authors: Barohn RJ,Herbelin L,Kissel JT,King W,McVey AL,Saperstein DS,Mendell JR

    更新日期:2006-01-24 00:00:00

  • Long-term survival and neurologic status after resuscitation from out-of-hospital cardiac arrest.

    abstract::Thirty-eight survivors from among 117 patients hospitalized after out-of-hospital cardiac arrest were evaluated approximately 3 1/2 years later. Twenty patients were living; 18 had died. Fifty-three percent had resumed independent social activities, but only 32% had returned to work. Eight of 14 patients tested were n...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.30.12.1298

    authors: Earnest MP,Yarnell PR,Merrill SL,Knapp GL

    更新日期:1980-12-01 00:00:00

  • Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD.

    abstract:BACKGROUND:Abeta42-immunization reduces plaque burden and improves cognition in transgenic mouse models of Alzheimer disease (AD). This phase 1 study evaluated the safety, tolerability, and immunogenicity of AN1792 (human aggregated Abeta42) in patients with mild to moderate AD. METHODS:Twenty patients were enrolled i...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1212/01.WNL.0000148604.77591.67

    authors: Bayer AJ,Bullock R,Jones RW,Wilkinson D,Paterson KR,Jenkins L,Millais SB,Donoghue S

    更新日期:2005-01-11 00:00:00

  • SOD1 missense mutation in an Italian family with ALS.

    abstract::We have discovered a new Italian pedigree with autosomal-dominant ALS. The pedigree, at present, comprises 75 members distributed in five generations. ALS was diagnosed in eight patients. The mean +/- SD age of onset of the disease was 46.8 +/- 13.5 years, with a range of 29 to 63 years. The mean +/- SD duration of th...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.44.2.347

    authors: Rainero I,Pinessi L,Tsuda T,Vignocchi MG,Vaula G,Calvi L,Cerrato P,Rossi B,Bergamini L,McLachlan DR

    更新日期:1994-02-01 00:00:00

  • Clinical decision-making in functional and hyperkinetic movement disorders.

    abstract:OBJECTIVE:Functional or psychogenic movement disorders (FMD) present a diagnostic challenge. To diagnose FMD, clinicians must have experience with signs typical of FMD and distinguishing features from other hyperkinetic disorders. The aim of this study was to clarify the decision-making process of expert clinicians whi...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000003479

    authors: van der Salm SM,van Rootselaar AF,Cath DC,de Haan RJ,Koelman JH,Tijssen MA

    更新日期:2017-01-10 00:00:00

  • Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis.

    abstract:OBJECTIVE:To characterize patterns of cognitive functioning in a well-defined group of patients with MRI-identified coexisting left temporal lobe developmental malformations (TLDM) and mesial temporal sclerosis (MTS), and to examine neuropsychological outcome in this dual-pathology group following epilepsy surgery. ME...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.53.4.709

    authors: Martin R,Dowler R,Gilliam F,Faught E,Morawetz R,Kuzniecky R

    更新日期:1999-09-11 00:00:00

  • Mild cognitive impairment: long-term course of four clinical subtypes.

    abstract:OBJECTIVE:To empirically validate the expanded concept of mild cognitive impairment (MCI), which differentiates between four clinical subtypes-amnestic MCI-single domain, amnestic MCI-multiple domains, nonamnestic MCI-single domain, and nonamnestic MCI-multiple domains-and to examine the prevalence, course, and outcome...

    journal_title:Neurology

    pub_type: 杂志文章,随机对照试验

    doi:10.1212/01.wnl.0000249117.23318.e1

    authors: Busse A,Hensel A,Gühne U,Angermeyer MC,Riedel-Heller SG

    更新日期:2006-12-26 00:00:00

  • Effects of cannabis on cognitive function in patients with multiple sclerosis.

    abstract:BACKGROUND:While neuropsychological deficits have been reported in healthy individuals who use street cannabis, data in patients with multiple sclerosis (MS) are lacking. Given that MS is associated with cognitive deterioration, the aim of this study was to determine the neuropsychological effects of cannabis use in th...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e318212ab0c

    authors: Honarmand K,Tierney MC,O'Connor P,Feinstein A

    更新日期:2011-03-29 00:00:00

  • Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia.

    abstract:BACKGROUND:Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder characterized by episodic hyperkinetic movement attacks. We have recently identified mutations in the MR-1 gene causing familial PNKD. METHODS:We reviewed the clinical features of 14 kindreds with familial dyskinesia that was not clearly induced...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000262029.91552.e0

    authors: Bruno MK,Lee HY,Auburger GW,Friedman A,Nielsen JE,Lang AE,Bertini E,Van Bogaert P,Averyanov Y,Hallett M,Gwinn-Hardy K,Sorenson B,Pandolfo M,Kwiecinski H,Servidei S,Fu YH,Ptácek L

    更新日期:2007-05-22 00:00:00

  • Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals.

    abstract::We studied the cerebral effects of oxygen-derived free radicals generated from the xanthine oxidase/hypoxanthine/ADP-Fe3+ system. Xanthine oxidase/hypoxanthine/ADP-Fe3+ solution (0.1 ml) was infused into caudate putamen, and brain was frozen rapidly in situ. Brain water and sodium content increased concomitant with de...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.34.3.315

    authors: Chan PH,Schmidley JW,Fishman RA,Longar SM

    更新日期:1984-03-01 00:00:00

  • Spontaneous intracranial hypotension resulting in stupor caused by diencephalic compression.

    abstract::A 51-year-old man had a 4-month history of progressive headache and gradual onset of somnolence. MRI suggested spontaneous intracranial hypotension (SIH) with diencephalic compression, but he did not improve after three epidural blood patches. He became alert following intrathecal saline infusion that normalized his C...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.50.6.1854

    authors: Pleasure SJ,Abosch A,Friedman J,Ko NU,Barbaro N,Dillon W,Fishman RA,Poncelet AN

    更新日期:1998-06-01 00:00:00

  • Individual differences in endogenous pain modulation as a risk factor for chronic pain.

    abstract::This review summarizes evidence, primarily from recent human studies, indirectly supporting a novel hypothesis: that the assessment of healthy individuals' responses to standardized noxious stimuli in a controlled laboratory environment has important implications for the later risk of developing a broad spectrum of ch...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/01.wnl.0000171862.17301.84

    authors: Edwards RR

    更新日期:2005-08-09 00:00:00

  • Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.

    abstract:OBJECTIVE:To assess the onset of ocrelizumab efficacy on brain MRI measures of disease activity in the phase II study in relapsing-remitting multiple sclerosis (RRMS), and relapse rate in the pooled phase III studies in relapsing multiple sclerosis (RMS). METHODS:Brain MRI activity was determined in the phase II trial...

    journal_title:Neurology

    pub_type: 杂志文章,随机对照试验

    doi:10.1212/WNL.0000000000008189

    authors: Barkhof F,Kappos L,Wolinsky JS,Li DKB,Bar-Or A,Hartung HP,Belachew S,Han J,Julian L,Sauter A,Napieralski J,Koendgen H,Hauser SL

    更新日期:2019-11-05 00:00:00

  • Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.

    abstract::Some epilepsy patients quickly develop resistance to antiepileptic drugs (AEDs). We report a case of a patient with refractory epilepsy with daily seizures who initially responded to levetiracetam daily therapy, but then returned to baseline seizure frequency. However, when levetiracetam was given once weekly, the pat...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000198500.84481.da

    authors: Friedman D,French JA

    更新日期:2006-02-28 00:00:00

  • Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease.

    abstract::We detected crossed cerebellar as well as uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease by positron emission tomography (PET) using 18F-fluorodeoxyglucose. We studied a series of 26 consecutive, clinically diagnosed Alzheimer cases, including 6 proven by later autopsy, and compared them with 9...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.39.4.541

    authors: Akiyama H,Harrop R,McGeer PL,Peppard R,McGeer EG

    更新日期:1989-04-01 00:00:00

  • Is late-onset multiple sclerosis associated with a worse outcome?

    abstract:OBJECTIVE:To describe the characteristics of late-onset multiple sclerosis (MS) (LOMS, 50+ years) vs adult-onset MS (AOMS, 16 to <50 years) and examine prognosis and associated risk factors. METHODS:Patients with definite MS, onset prior to July 1988, registered with a BCMS clinic before July 1998, with at least one E...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000237475.01655.9d

    authors: Tremlett H,Devonshire V

    更新日期:2006-09-26 00:00:00

  • Insulin resistance among obese middle-aged is associated with decreased cerebrovascular reactivity.

    abstract:OBJECTIVE:To evaluate differences in cerebrovascular reactivity (CVR) to mild hypercapnia in obese/overweight individuals with and without insulin resistance (IR) compared to comparable lean controls. METHODS:A total of 60 cognitively normal participants (20 lean controls and 24 obese/overweight individuals with and 1...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000004110

    authors: Frosch OH,Yau PL,Osorio RS,Rusinek H,Storey P,Convit A

    更新日期:2017-07-18 00:00:00